Regular aspirin use, breast tumor characteristics and long-term breast cancer survival by Cheng Peng, Tengteng Wang, Michelle D. Holmes, Wendy Y. Chen, Kristen D. Brantley, Phuong Anh Le, Yujing J. Heng, Pepper J. Schedin, Bernard A. Rosner, Walter C. Willett, Meir J. Stampfer, Rulla M. Tamimi, A. Heather Eliassen

“…npj Breast Cancer…”
Get full text

Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative by Su-Jin Shin, Inho Park, Heounjeong Go, Jiwon Ko, Yangkyu Lee, Jee Hung Kim, Sung Gwe Ahn, Joon Jeong, Soong June Bae, Yoon Jin Cha

“…npj Breast Cancer…”
Get full text

Spatial biomarkers of response to eribulin plus pembrolizumab in patients with metastatic triple negative breast cancer in the ENHANCE-1 trial by Yee Hoon Foong, Qi Wang, Matthew Kearney, Hortense Le, Hua Guo, Diane Chen, Michelle Garlin Politis, Courtney F. Connelly, Kevin Kalinsky, Rami S. Vanguri, Eileen P. Connolly

“…npj Breast Cancer…”
Get full text

Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasets by Brooke M. Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, Adam D. Pfefferle, Michele C. Hayward, Katherine A. Hoadley, Naim U. Rashid, Sara M. Tolaney, George Somlo, Lisa A. Carey, William M. Sikov, Charles M. Perou

“…npj Breast Cancer…”
Get full text

Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy by Luca Mastrantoni, Giovanna Garufi, Giulia Giordano, Noemi Maliziola, Elena Di Monte, Giorgia Arcuri, Valentina Frescura, Angelachiara Rotondi, Armando Orlandi, Luisa Carbognin, Antonella Palazzo, Federica Miglietta, Letizia Pontolillo, Alessandra Fabi, Lorenzo Gerratana, Sergio Pannunzio, Ida Paris, Sara Pilotto, Fabio Marazzi, Antonio Franco, Gianluca Franceschini, Maria Vittoria Dieci, Roberta Mazzeo, Fabio Puglisi, Valentina Guarneri, Michele Milella, Giovanni Scambia, Diana Giannarelli, Giampaolo Tortora, Emilio Bria

“…npj Breast Cancer…”
Get full text

Personalized neoadjuvant strategy using 70-gene assay to increase breast-conserving surgery in ER+/HER2– breast cancer by Wonshik Han, Eunhye Kang, Ji Gwang Jung, Hong-Kyu Kim, Han-Byoel Lee, Jisun Kim, Sae Byul Lee, Hee-Chul Shin, Chan Sub Park, Min-Ki Seong, Hyun-Ah Kim, Eun-Kyu Kim, Byung Ho Son

“…npj Breast Cancer…”
Get full text

Biomarkers of palbociclib response in hormone receptor-positive advanced breast cancer from the PARSIFAL trial by Joan Albanell, Angelo Gámez Pozo, Carlos L. Arteaga, Meritxell Bellet, Federico Rojo, Abel González, Beatriz Bellosillo, Violeta Serra, Petra Gener, José Antonio Guerrero, Eileen Shimizu, Mario Mancino, Jose Rodríguez-Morató, Leonardo Mina, José Manuel Pérez-García, Javier Cortés, Antonio Llombart-Cussac

“…npj Breast Cancer…”
Get full text

Genomic landscape of breast cancer in elderly patients by Pier Selenica, Higinio Dopeso, Matteo Repetto, Thais Basili, Andrea M. Gazzo, Christopher J. Schwartz, Fatemeh Derakhshan, Antonio Marra, Lorenzo Ferrando, Regina G. H. Beets-Tan, Y. H. Wen, Dara S. Ross, Edi Brogi, Hong Zhang, Larry Norton, Sarat Chandarlapaty, Pedram Razavi, Diana Mandelker, Jorge S. Reis-Fiho, Britta Weigelt, Fresia Pareja

“…npj Breast Cancer…”
Get full text

Immunotherapy for hormone receptor‒positive HER2-negative breast cancer by Fatima Cardoso, Kim M. Hirshfield, Kimberly A. Kraynyak, Konstantinos Tryfonidis, Aditya Bardia

“…npj Breast Cancer…”
Get full text

Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification by Kristin Galas, Moritz Gleitsmann, Julia Rey, Christine Solbach, Isabell Witzel, Thomas Karn, Sabine Schmatloch, Christian Schem, Andreas Schneeweis, Bruno Sinn, Tanja Fehm, Carsten Denkert, Peter Fasching, Anne-Sophie Litmeyer, Frederik Marmé, Paul Jank, Volkmar Müller, Sabine Seiler, Elmar Stickeler, Olaf Ortmann, Marion van Mackelenbergh, Valentina Nekljudova, Johannes Holtschmidt, Sibylle Loibl

“…npj Breast Cancer…”
Get full text

The interplay between FOXO3 and FOXM1 influences sensitivity to AKT inhibition in PIK3CA and PIK3CA/PTEN altered estrogen receptor positive breast cancer by Valentina Cutano, Ming Li Chia, Eleanor M. Wigmore, Lorna Hopcroft, Stuart C. Williamson, Amanda L. Christie, Brandon Willis, James Kerr, Jenny Ashforth, Rhys Fox, Sophie D’Arcy, Lauren Bradshaw, Catherine Blaker, Cath Eberlein, Lambert Montava-Garriga, Elza C. de Bruin, Susan E. Critchlow, Kevin M. Brindle, Simon T. Barry, Susana Ros

“…npj Breast Cancer…”
Get full text

Quantitative analysis of T cell subsets in a population of Black women with invasive breast cancer by Angela R. Omilian, Lucas Mendicino, Anthony George, Tina Darabnoushtehrani, Rochelle Payne Ondracek, Wiam Bshara, Chi-Chen Hong, Bo Qin, Elisa V. Bandera, Thaer Khoury, Rikki Cannioto, Song Yao, Christine B. Ambrosone

“…npj Breast Cancer…”
Get full text

Biological correlates associated with high-risk breast cancer patients identified using a computational method by Jung Hun Oh, Fresia Pareja, Rena Elkin, Kaiming Xu, Larry Norton, Joseph O. Deasy

“…npj Breast Cancer…”
Get full text

Clinico-pathological predictors of radiologic complete response to first-line anti-HER2 therapy in metastatic breast cancer by Linda Cucciniello, Eva Blondeaux, Claudia Bighin, Simona Gasparro, Stefania Russo, Arianna Dri, Palma Pugliese, Andrea Fontana, Enrico Cortesi, Antonella Ferzi, Ferdinando Riccardi, Valentina Sini, Luca Boni, Alessandra Fabi, Filippo Montemurro, Michelino De Laurentiis, Grazia Arpino, Lucia Del Mastro, Lorenzo Gerratana, Fabio Puglisi

“…npj Breast Cancer…”
Get full text

Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patients by Xiaopeng Sun, Margaret L. Axelrod, Adrienne G. Waks, Jingxin Fu, Molly DiLullo, Eliezer M. Van Allen, Sara M. Tolaney, Elizabeth A. Mittendorf, Yaomin Xu, Justin M. Balko

“…npj Breast Cancer…”
Get full text

Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment by Beatrice Taurelli Salimbeni, Fabiola Giudici, Carlo Pescia, Pier Paolo Maria Berton Giachetti, Roberta Scafetta, Paola Zagami, Antonio Marra, Dario Trapani, Angela Esposito, Simone Scagnoli, Bruna Cerbelli, Andrea Botticelli, Elisabetta Munzone, Nicola Fusco, Carmen Criscitiello, Giuseppe Curigliano

“…npj Breast Cancer…”
Get full text

A systematic review of determinants of breast cancer risk among women with benign breast disease by Aileen Burke, Jessica O’Driscoll, Mustapha Abubakar, Kathleen E. Bennett, Emma Carmody, Fidelma Flanagan, Gretchen L. Gierach, Maeve Mullooly

“…npj Breast Cancer…”
Get full text

Treatment patterns and clinical outcomes of patients with HER2-positive T1micN0 breast cancer: a single-center analysis by Celine Yeh, Rachel Han, Abha Kulkarni, Charlie White, Yuan Chen, Matthew G. Hanna, Edi Brogi, Andrew D. Seidman

“…npj Breast Cancer…”
Get full text

A multi-model approach integrating whole-slide imaging and clinicopathologic features to predict breast cancer recurrence risk by Manu Goyal, Jonathan D. Marotti, Adrienne A. Workman, Graham M. Tooker, Seth K. Ramin, Elaine P. Kuhn, Mary D. Chamberlin, Roberta M. diFlorio-Alexander, Saeed Hassanpour

“…npj Breast Cancer…”
Get full text

Trends in contralateral breast cancer and contralateral prophylactic mastectomy from 2009 to 2016 by Shana J. Kim, Jasleen Arneja, Rebecca A. G. Christensen, Geoff M. Anderson, Jennifer D. Brooks

“…npj Breast Cancer…”
Get full text